Design Therapeutics Inc (DSGN) — Defensive Interval Ratio
Design Therapeutics Inc (DSGN) has a Defensive Interval Ratio of 6281 days as of September 2025. Defensive assets of $192.26 Million (cash $-, short-term investments $190.88 Million, receivables $1.38 Million) cover 6281 days of daily cash needs of $30.61K/day. See DSGN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Design Therapeutics Inc Defensive Interval Ratio (2019–2024)
This chart shows how Design Therapeutics Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 6281 days, meaning defensive assets of $192.26 Million can fund 6281 days of operations without new revenue. See DSGN net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Design Therapeutics Inc (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Design Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Design Therapeutics Inc (DSGN) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 9670 days | $224.18 Million | $23.18K/day | $- | $222.91 Million | ▼ -270 days |
| 2023 | 9940 days | $262.03 Million | $26.36K/day | $- | $260.60 Million | ▼ -391 days |
| 2022 | 10331 days | $305.00 Million | $29.52K/day | $- | $303.89 Million | ▲ +4416 days |
| 2021 | 5914 days | $85.61 Million | $14.47K/day | $- | $85.50 Million | ▲ +632 days |
| 2020 | 5283 days | $33.72 Million | $6.38K/day | $- | $33.71 Million | ▲ +5283 days |
| 2019 | 0 days | $0.00 | $10.22K/day | $- | $0.00 | — |